In Brief
The cellular origin of basal cell carcinoma (BCC), the most common cancer, has been controversial. Here, Peterson et al. report that BCCs primarily arise from stem cells within hair follicle and mechanosensory touch dome epithelia and further demonstrate that cutaneous nerves maintain touch dome identity and promote tumorigenesis.
INTRODUCTION
Dysregulated Hedgehog (Hh) signaling is a hallmark of basal cell carcinoma (BCC), the most common cancer in North America (Epstein, 2008; Kasper et al., 2012) . During development and homeostasis, Hh is carefully regulated by a balance of upstream factors that can either promote signaling, such as Smoothened (Smo) , or suppress signaling, such as Patched1 (Ptch1). In BCC, this balance is tilted decisively in favor of pathway activation through mutations that cause either loss of PTCH1 function or constitutive activation of SMO (Johnson et al., 1996; Xie et al., 1998) .
Early evidence implicating perturbed Hh in BCC came from studies demonstrating that patients harboring defective PTCH1 alleles are predisposed to developing numerous BCCs (Gorlin's syndrome) (Bonifas et al., 1994; Hahn et al., 1996; Johnson et al., 1996) . Similarly, loss of Ptch1 promotes BCC-like lesions in irradiated mice (Aszterbaum et al., 1999) , as does overexpression of mutated forms of Smo, Sonic hedgehog, or downstream Gli transcription factors (Grachtchouk et al., 2000; Mao et al., 2006; Nilsson et al., 2000; Oro and Higgins, 2003; Oro et al., 1997; Xie et al., 1998) . Findings from these and other studies have recently culminated in the USA Food and Drug Administration's approval of , an oral inhibitor of SMO, as a therapeutic for treating advanced BCC.
In the skin, multiple stem cell populations maintain tissue homeostasis and contribute to organ regeneration during hair cycling (Jaks et al., 2010) . In trying to identify the stem cells that give rise to BCC, however, recent studies have yielded conflicting results . For instance, work by Youssef et al. (2010) has suggested that hair follicle bulge stem cells expressing a constitutively active form of Smo (SmoM2) resist BCC formation. Rather, these tumors arise primarily from the interfollicular epidermis (IFE), which we have also observed in intact and wounded skin (Wong and Reiter, 2011) . In direct contrast, lineage tracing experiments by Wang et al. (2011) using irradiated Ptch1 heterozygous animals have suggested that Keratin 15+ bulge stem cells are the primary progenitors for BCC. A third possibility-that stem cells in the epidermis and bulge are both competent for tumorigenesis-has also been proposed for tumors induced by an activated form of Gli2 (Grachtchouk et al., 2011) .
These discrepant results are likely due to the use of different animal models whereby, in some cases, oncogenic transgenes such as SmoM2 are driven by heterologous promoters. Because up to 90% of human BCCs are thought to be caused by loss of PTCH1, mouse models that target deletion of Ptch1 to specific skin compartments may serve as more accurate models of human disease. Indeed, deletion of Ptch1 in Lgr5+ stem cells in the lower bulge and secondary hair germ has been reported to yield BCC-like tumors (Kasper et al., 2011) . Whether other stem cell populations residing in the hair follicle and IFE possess tumor-forming capacity currently remains unclear.
Here we demonstrate that multiple hair follicle stem cell populations are highly tumorigenic upon deletion of Ptch1, whereas most stem cells within the IFE do not efficiently form tumors. However, an innervated subset of IFE cells known as touch dome (TD) epithelia display activated Hh signaling during homeostasis and are highly susceptible to tumorigenesis. Surgical nerve ablation blunted the formation of TD-derived lesions, suggesting that cutaneous sensory nerves may play a previously unrecognized role in skin cancer.
RESULTS

BCC-like Tumors Can Arise from Multiple Hair Follicle Stem Cell Populations
A hair follicle origin for BCC has long been suggested on the basis of similarities in marker expression (Jih et al., 1999; Schirren et al., 1997) . Because the hair follicle is maintained by several independent stem cell populations, we directly tested whether these cells are able to form tumors upon loss of Ptch1. To target Ptch1 deletion to specific hair follicle compartments, we generated mice harboring homozygous Ptch1 floxed alleles (Nitzki et al., 2012) coupled with different tamoxifen-inducible Cre drivers ( Figure 1A ). We treated mice with tamoxifen at 7.5 weeks of age, then harvested skin biopsies several weeks post-induction to assess tumor formation.
During telogen, stem cells expressing the Hh target gene Gli1 reside within the hair follicle upper and lower bulge and secondary hair germ (Brownell et al., 2011) . In mice expressing Gli1 promoter-driven Cre ERT2 and Ptch1 floxed alleles (Gli1;Ptch1), we observed robust tumor formation 5 weeks after tamoxifen induction ( Figure 1B ). These tumors appeared well circumscribed and displayed BCC-like features such as peripheral basal palisading ( Figure 1C ). As expected, these lesions were typically connected to the hair follicle upper and lower bulge, but not the infundibulum, consistent with the lack of contribution of Gli1+ stem cells to the hair canal (Brownell et al., 2011) . Although Gli1+ cells can contribute to regenerating hair follicles during anagen, we did not observe tumors associated with the lower anagen follicle, suggesting that matrix cells cannot give rise to BCCs ( Figure S1 ).
We have recently reported that mice expressing Hes1 promoter-driven Cre ERT2 display recombinase activity in suprabasal cells of the IFE and infundibulum (Veniaminova et al., 2013) . By coupling this recombinase with an inducible ROSA26R promoter-driven YFP reporter allele, we also observed Cre activity in inner bulge and, less frequently, in outer bulge stem cells (Figure 1D) . We therefore assessed tumor formation in mice expressing this Cre along with Ptch1 floxed alleles (Hes1;Ptch1), and observed upper and lower bulge-associated lesions similar to those in Gli1;Ptch1 animals, within 7 weeks after tamoxifen induction ( Figure 1E ). Together, these data confirm that bulge stem cells can indeed serve as tumor progenitors.
To test whether other stem cell populations can form BCCs, we next focused on Lrig1+ cells in the isthmus. Under homeostatic conditions, these cells renew the hair follicle infundibulum independently of bulge stem cells, because bulge cells largely do not contribute to the infundibulum, while Lrig1+ stem cells do not contribute to the bulge or anagen follicle (Page et al., 2013; Veniaminova et al., 2013) . In mice expressing Lrig1 promoter-driven Cre ERT2 and Ptch1 floxed alleles (Lrig1;Ptch1), we observed numerous tumors associated with the isthmus and infundibulum 5 weeks after tamoxifen induction ( Figure 1F ). These findings therefore reveal that BCC-like tumors can originate from upper bulge, lower bulge, and isthmus progenitor populations in the hair follicle.
The IFE Displays Reduced Tumor-Forming Capacity
To determine whether the epidermis is susceptible to tumorigenesis, we deleted Ptch1 in the IFE using mice expressing Keratin 14 promoter-driven Cre ERT (K14;Ptch1). We and others have previously shown that this recombinase displays robust activity in the IFE but minimal activity in the hair follicle (Wong and Reiter, 2011; Zhang et al., 2009) , as confirmed here using the YFP reporter allele (Figure 2A) . Surprisingly, K14;Ptch1 mice did not develop tumors in the epidermis 5 weeks after induction. Even after extending the interval between tamoxifen treatment and biopsy to 12 weeks, we noticed that K14;Ptch1 animals typically possessed a hyperplastic epidermis containing small, ectopic hair follicle-like buds resembling early benign follicular hamartomas ( Figure 2B ). Larger lesions adjacent to the IFE radiated laterally from the hair follicle infundibulum and did not display a connection to the epidermis, as confirmed by examining serial sections (Figures 2B and S2) .
Previous studies have found that P53 mutations are common in human BCC and that loss of p53 can promote BCCs in the IFE of irradiated Ptch1-heterozygous mice (Ponté n et al., 1997; Wang et al., 2011) . We therefore assessed tumor formation in K14;Ptch1 mice that additionally harbored homozygous floxed alleles of p53. In mice biopsied up to 12 weeks after tamoxifen treatment, however, we observed that loss of p53 did not enhance IFE tumorigenesis ( Figure 2C ). In stark contrast, Gli1;Ptch1, Hes1;Ptch1 and Lrig1;Ptch1 mice with wild-type p53 all developed large hair follicle-associated lesions that filled the dermis within 5 to 7 weeks post-induction ( Figure 1 ). These findings indicate that BCC-like tumors preferentially develop from hair follicle stem cells and that loss of p53 does not promote IFE tumor formation.
Hair Follicle-Derived Tumors Express Similar Markers Irrespective of Stem Cell Origin
Given our finding that BCC-like lesions can originate from multiple hair follicle stem cell populations, we next determined whether these tumors display differences in marker expression. Regardless of cellular origin, all hair follicle-derived tumors consistently expressed K14 as well as K17, a Hh pathway target gene (Callahan et al., 2004) (Figures 3A and 3B) . K17 was also upregulated throughout the hyperplastic epidermis of induced K14;Ptch1 animals, indicating that IFE stem cells which had deleted Ptch1 remained in the epidermis and activated downstream Hh signaling in spite of the absence of tumors.
All hair follicle-derived tumors also expressed the stem markers Sox9 and Lrig1 ( Figures 3C and 3D ). At the same time, these tumors sometimes exhibited signs of early differentiation, as evidenced by expression of K10 ( Figure 3E ). In contrast, involucrin, a later differentiation marker, was not observed (Figure 3F ). Because we were ultimately unable to detect differential marker expression, this suggests that all hair follicle-derived tumors display a similar phenotype irrespective of cellular origin.
BCC-like Tumors Efficiently Arise from Stem Cells within Touch Dome Epithelia
Although the IFE was largely devoid of tumors, we noticed that Gli1;Ptch1 mice frequently developed branched lesions that radiated down from the epidermis specifically at sites adjacent to guard hairs ( Figure 4A ). Because mechanosensory TD epithelia are localized to guard hairs, we re-evaluated the activity of Gli1-Cre ERT2 by generating mice expressing the recombinase along with either an inducible ROSA26R promoter-driven b-galactosidase (LacZ) or YFP reporter allele (Gli1;LacZ or Gli1;YFP, respectively). After tamoxifen induction, these mice indeed displayed reporter gene expression in TDs, as determined both by whole-mount staining for LacZ and by co-localizing YFP with K17, a marker of TDs (Doucet et al., 2013; Moll et al., 1993 ) ( Figure 4B ). TD labeling was stably maintained in the long term ( Figures 4B and S3 ), suggesting that TDs are renewed by dedicated stem cell pools that display Hh pathway activity during homeostasis.
It is interesting to note that normal TDs typically consist of keratinocytes displaying a columnar basal morphology resembling the peripheral palisades observed in hair follicle-associated BCC-like tumors ( Figure 4C ). To establish that epidermis-associated Gli1;Ptch1 tumors are derived from TDs, we examined tumor formation at earlier time points and observed a gradual lateral as well as downward expansion of K17+ TD-derived cell clusters upon deletion of Ptch1 ( Figures 4D and 4E ). Just as normal TDs are juxtaposed by innervated neuroendocrine Merkel cells (Moll et al., 2005) , epidermis-associated tumors in Gli1;Ptch1 mice were also lined by Merkel cells, as assessed by staining for the marker K8 ( Figure 4D ). In addition, neurofilament staining confirmed that tumor-associated Merkel cells were innervated by sensory afferents ( Figure 4F ). In contrast, Merkel cells were never detected near any hair follicle-associated tumors ( Figure 4F ).
Infrequently, we also observed more extensive epidermisassociated lesions in K14;Ptch1 mice ( Figure 4G ). These tumors resembled those arising from the TD in Gli1;Ptch1 animals, and staining for K8 confirmed the presence of Merkel cells localized to these tumors ( Figure 4G ). To assess whether K14-Cre ERT can induce recombination in the TD, we analyzed mice expressing the recombinase along with the YFP reporter allele (K14;YFP). Indeed, TD epithelia were occasionally labeled in K14;YFP animals, although at a frequency that was significantly reduced compared with either IFE labeling outside of TDs or labeling within TDs in Gli1;YFP mice ( Figures 4H and 4I ). Diminished K14-Cre ERT activity in the TD is likely due to reduced expression of K14 in TDs relative to the rest of the IFE, which is apparent only upon high dilution (1:1,000,000) of an antibody against this keratin ( Figure 4J ). Altogether, our findings suggest that TD epithelia activate Hh signaling during homeostasis and, unlike the rest of the IFE, are highly susceptible to forming BCC-like lesions upon loss of Ptch1.
Surgical Denervation Inhibits Tumorigenesis
Surgical nerve ablation has been reported to cause loss of TDs and Merkel cells in rodent and feline skin (English et al., 1983; Nurse et al., 1984) . To confirm these findings, we denervated thoracic-level cutaneous nerves to one side of the dorsal midline in 6-week-old wild-type mice, while leaving the contralateral side intact as a sham control. After collecting samples 3 or 5 weeks after surgery, we observed that denervated skin displayed a Figure 5B ), possibly subsequent to K17 downregulation ( Figure S3 ), while remaining Merkel cells were frequently not innervated (Figure 5C) . To further assess Hh activity after denervation, we denervated 6-week-old Gli1;LacZ mice and treated these animals with tamoxifen 2 weeks after surgery ( Figure 5D ). Four days later, we harvested biopsies for LacZ staining and observed reduced TD labeling compared with intact contralateral control ( Figure 5D ). Given that K17 and Gli1 are both downstream targets of Hh signaling, these findings suggest that cutaneous nerves are crucial for maintaining Hh pathway activity in the TD niche.
We next extended these studies to determine whether denervation can inhibit TD-derived tumors in Gli1;Ptch1 mice. To first confirm that denervation performed subsequent to tamoxifen induction does not affect Gli1-Cre ERT2 recombinase activity in the TD, we induced Gli1;LacZ mice with tamoxifen at 5.5 weeks of age, then subsequently denervated one side of the dorsal skin 4 days after induction ( Figure 6A ). Two weeks after nerve ablation, we harvested skin biopsies and observed similar patterns of LacZ staining in denervated and sham-operated skin (Figure 6A ). Thus, although TD epithelia rely on nerves to activate Hh ( Figures 5B and 5D ), nerve ablation and consequent loss of Hh pathway activity do not immediately affect the abundance or distribution of already-labeled cells in the TD, which can persist for weeks without neural input (English et al., 1983; Nurse et al., 1984) .
In Gli1;Ptch1 mice, we used the same approach, inducing animals with tamoxifen at 5.5 weeks of age and subsequently denervating one side of the skin ( Figure 6B ). Two or five weeks after tamoxifen induction, we harvested biopsies and confirmed that cutaneous nerves were stably ablated ( Figure S4 ). Although denervation did not affect tumor growth 2 weeks post-induction, we observed a significant inhibition of TD-derived tumors in denervated skin 5 weeks after tamoxifen treatment ( Figures 6B  and 6C ). In nine of ten mice, fewer TD-derived tumor cells were observed within denervated skin, compared with the contralateral sham control (mean = 81.3 versus 35.3 TD-derived tumor cells/cm for sham versus denervated skin, respectively; p = 0.017 by paired Student's t test). In addition, the number of Merkel cells associated with these tumors was also reduced ( Figure 6C ). This effect was specific to TD-derived tumors, as nerve ablation did not significantly affect adjacent hair follicleassociated lesions ( Figure 6D ), arguing that denervation does not induce a systemic anti-tumorigenic response.
If epidermis-associated tumors that develop infrequently in K14;Ptch1 mice are derived exclusively from TDs, denervation should also prevent BCC-like lesions in these animals. We therefore surgically removed the nerves from dorsal back skin in 6-week-old K14;Ptch1 mice, exposed these animals to tamoxifen 2 weeks after surgery, and harvested biopsies after an additional 5 weeks. Although nerve ablation did not affect K14-Cre ERT -mediated recombination in the IFE (Figure 6E) , the formation of rare TD-derived lesions was attenuated in denervated skin (mean = 20.7 versus 3.9 TD-derived tumor cells/cm for sham versus denervated skin, respectively; p = 0.04 by paired Student's t test) ( Figure 6F ). In contrast, the formation of small ectopic buds along the IFE was unaffected. Together, our findings in K14;Ptch1 and Gli1;Ptch1 mice indicate that epidermisassociated tumors preferentially arise from TD epithelia and that sensory nerves promote progression of TD-derived tumors.
The Mechanosensory Niche Promotes Tumorigenesis
How does the perineural microenvironment foster a pro-tumorigenic niche? Because TDs display heightened Gli1 expression, we investigated the possibility that paracrine signals released by nerves can promote canonical Hh signaling in the TD. In mammals, three Hh ligands-Shh, Dhh, and Ihh-activate the pathway. After dissecting dorsal root ganglia, where cell bodies of cutaneous sensory nerves are located, we determined by qRT-PCR that these nerves express markedly higher levels of all three Hh ligands compared with skin epithelia ( Figure 7A ). These findings are concordant with recent data showing that neuron-specific loss of Shh causes deterioration of TDs and Merkel cells in adult mice (Y. Xiao and I. Brownell, personal communication) .
Although the loss of Ptch1 may seemingly bypass the requirement for Hh ligands to induce pathway activity in TD-derived tumors, recent studies have shown that Ptch1-deficient skin upregulates a related protein, Ptch2, which can also bind Hh ligands and suppress downstream signaling (Adolphe et al., 2014) . Indeed, we confirmed by qRT-PCR that Ptch2 expression was increased upon deletion of Ptch1 in K14;Ptch1 mice, suggesting that Ptch2 may dampen Hh signaling in tumor-resistant IFE ( Figure 7B ).
To further elucidate why different skin compartments vary in tumor predisposition, we searched for molecular differences that might distinguish tumor-susceptible hair follicle and TD compartments, from tumor-resistant IFE. The cell surface glycoprotein CD200 is a marker of hair follicle stem cells in humans and may promote immune privilege in various organs (Garza et al., 2011) . CD200 has also recently been found to be enriched in cells that can initiate BCC (Colmont et al., 2013) . In mice, CD200 is a marker of TD epithelia (Woo et al., 2010) , and we also observed CD200 throughout the hair follicle, but not in the IFE (Figure 7C ). Furthermore, all hair follicle-and TD-derived tumors strongly expressed CD200, whereas strikingly, CD200 was completely absent from hyperplastic IFE or weakly expressed in ectopic IFE buds in K14;Ptch1 mice ( Figure 7D ). In keratinocytes, either loss of Ptch1 or pharmacological activation of Hh signaling elevated CD200 (Figures 7E and 7F) . Together, these findings suggest that in tumor-resistant IFE, loss of Ptch1 only partially activates the Hh signaling program, leading to upregulation of some target genes (Gli1, Ptch2, K17), but not others (CD200) ( Figures 7B and S5 ). Within the TD niche, nerve-derived factors, possibly involving Hh ligands, may potentiate full pathway activation and tumorigenesis. Notably, as normal TDs resemble BCCs in terms of basal columnar morphology as well as elevated baseline expression of Gli1, K17 and CD200, this once again argues that TDs are ''hot spots'' in the epidermis that are primed for tumor formation.
DISCUSSION
The precise cellular origin of BCC has been controversial, as recent studies have seemingly yielded diametrically opposed results. Whereas SmoM2-induced BCC-like tumors appear to arise from stem cells in the IFE, but not from the hair follicle bulge (Wong and Reiter, 2011; Youssef et al., 2010) , tumors driven by loss of Ptch1 have been reported to originate from the bulge and secondary hair germ, but not the IFE (Kasper et al., 2011; Wang et al., 2011) . Our results are concordant with those of Wang et al. (2011) and Kasper et al. (2011) , although we have identified additional stem cell populations that are also susceptible to tumorigenesis. Altogether, using a mouse model that recapitulates the most common genetic aberration seen in human BCCs, our findings indicate that these tumors preferentially arise from stem cells located specifically in the upper bulge, lower bulge/ secondary hair germ, isthmus, and TD, but not from IFE stem cells or transit-amplifying matrix cells ( Figure 7G) .
What predisposes certain cutaneous epithelia to forming tumors upon loss of Ptch1? Previous studies have postulated that degradation of Gli proteins may restrict Hh signaling and BCC formation in the skin (Huntzicker et al., 2006; Oro and Higgins, 2003) . Supportive of this, Grachtchouk et al. (2011) showed that upon forced activation of downstream Hh signaling, BCClike tumors can arise from both hair follicles and IFE. Alternatively, upregulation of Ptch2 in the absence of Ptch1 may also restrain full Hh pathway activity. Indeed, Adolphe et al. (2014) recently demonstrated that mice lacking both Ptch1 and Ptch2 develop a more severe hyperplastic and BCC-like invaginating epidermal phenotype than do mice deficient for Ptch1 alone. Our findings are concordant with these observations and suggest that tumor-resistant IFE cells become oncogenic only upon high activation of Hh signaling requiring loss of multiple redundant inhibitors of the pathway. These data further suggest that sites in the skin which normally display high level Hh signaling are likely predisposed to BCC formation and that loss of Ptch1 alone at these sites is sufficient for tumorigenesis.
Consistent with this concept, we have found that TD epithelia display activated Hh signaling during homeostasis and are highly susceptible to forming tumors. Under normal conditions, TDs function as mechanosensory organs that detect light touch and transduce signals via underlying Merkel cells to slowly adapting type 1 sensory afferents (Maksimovic et al., 2014; Maricich et al., 2009) . We have further shown that cutaneous sensory nerves express Hh ligands and that denervation impairs Hh activity in the TD and inhibits the progression of TD-derived tumors. Although these results suggest that nerve endings secrete Hh ligands to promote TD-derived tumors, it is important to add, however, that TD-derived tumors did not appear to respond to a neutralizing antibody generated against Shh (Figure S6) . These results might be explained if multiple Hh ligands simultaneously promote TD-derived tumors, and tumor inhibition can be achieved only by complete and sustained impairment of Hh signaling, as might occur following long-term denervation. These findings do not rule out the possibility that nerves may also non-canonically activate downstream Hh signaling via pathways such as TGF-b (Nolan-Stevaux et al., 2009) . Alternatively, cutaneous nerves are known to secrete cytokines such as calcitonin gene-related peptide as well as substance P, which can serve functional roles during epidermal development and pathology . Indeed, neural changes are often observed in patients with psoriasis and atopic eczema, and nerve removal inhibits the epidermal hyperplasia observed in experimental models of these diseases (Ostrowski et al., 2011; Ward et al., 2012) .
Our findings complement those of previous studies showing that nerves can influence tumors in other organs. For instance, chemical denervation can inhibit tumorigenesis in the stomach and colon (Polli-Lopes et al., 2003) . More recent studies in prostate cancer have found that peritumoral sympathetic nerves promote tumor growth, while intratumoral parasympathetic nerves stimulate metastasis (Magnon et al., 2013) . In addition, b-blockers, which interfere with the sympathetic nervous system, can delay the progression of various cancers (Lemeshow et al., 2011) . A tumor-modulatory role for nerves has not been (legend continued on next page) described for Merkel cell carcinoma, a rare cancer thought to originate from Merkel cells, but would not be surprising given the close association between nerve endings and mechanosensory cells.
In humans, BCCs primarily develop in sun-exposed, hairbearing skin. In addition, the majority of tumors (between 57% and 78%) typically display a nodular phenotype, while only a minority (15%-16%) present as superficial lesions (Bastiaens et al., 1998; Scrivener et al., 2002) . Interestingly, Grachtchouk et al. (2011) previously noted in mice that tumors originating from hair follicles appear nodular, whereas IFE-associated tumors resemble superficial human BCCs, suggesting that tumor histologic phenotype can reflect cellular origin. From this perspective, the high prevalence of nodular human BCCs is consistent with our finding that hair follicle stem cells likely serve as the primary progenitors for these tumors. Although our studies do not exclude the possibility that loss of Ptch1 may give rise to tumors from the IFE after an extended latency, our findings also suggest that some human BCCs that appear to arise from the IFE might actually originate from the TD.
Because Merkel cells are invariably associated with TDderived tumors in our studies, we also examined the distribution of these cells in a limited number of human BCC samples. In four of ten tumors, we observed clusters of Merkel cells located within small tumor foci from both superficial and deeper lesions, but not within larger tumor masses ( Figures 7H and S7) . These observations are consistent with a potential mechanosensory niche for BCC, or possibly even ''micro-niches'' within the immediately vicinity of innervated Merkel cells, which in humans are widely distributed not just in TDs, but also throughout the skin and hair follicles (Lacour et al., 1991) . Moreover, these cells are particularly abundant in glabrous skin (Fradette et al., 1995) , where palmoplantar pits frequently develop in Gorlin's patients. Merkel cells have also been observed in a minority of human BCCs, including a subtype known as fibroepithelioma of Pinkus (Sellheyer and Nelson, 2011; Sellheyer et al., 2012) , but are more commonly associated with trichoblastoma (Schulz and Hartschuh, 1997) . It remains to be seen whether Merkel cells play an early supporting role during BCC tumor initiation, but are subsequently lost as the tumor expands. Further work will be required to determine whether both Merkel cells and nerves preferentially associate with specific BCC subtypes, or possibly early during tumorigenesis, and if so, whether targeting these niche elements might represent a viable therapeutic strategy.
EXPERIMENTAL PROCEDURES Animals
The following mice were used: Gli1 tm3(cre/ERT2)Alj (Ahn and Joyner, 2004) , Tg(KRT14-cre/ERT)20Efu (Vasioukhin et al., 1999) , Hes1 tm1(cre/ERT2)Lcm (Kopinke et al., 2011) , Lrig1 tm1.1(cre/ERT2)Rjc (Powell et al., 2012) , FVB.Cg-Tg(KRT1-5-cre)5132Jlj/Mmnc (Berton et al., 2003) , Gt(ROSA) 26Sor tm1Sor (Soriano, 1999) , Gt(ROSA)26Sor tm1(EYFP)Cos (Srinivas et al., 2001) , Ptch1 tm1Hahn (Uhmann et al., 2007) , and Trp53 tm1Brn (Marino et al., 2000) .
Mouse Manipulations
For tumor cell-of-origin experiments, animals were induced with tamoxifen at 7.5 weeks of age. For nerve studies, mice were induced and denervated according to the schedules described in the text. Tamoxifen doses were as follows: one dose at 5 mg per 40 g body weight for Gli1;Ptch1 and Hes1;Ptch1 mice; one dose at 1 mg per 40 g body weight for Lrig1;Ptch1 mice; and three daily doses, each 1 mg per 40 g body weight, for K14;Ptch1 mice. Skin biopsies were harvested as previously described (Wong and Reiter, 2011) . Denervation was adapted from previously described procedures (Ostrowski et al., 2011) . Briefly, mice were anesthetized, and a 4.5 to 5 cm incision was made along the dorsal midline to expose cutaneous nerves on the left side (T3-12). These were blunt dissected close to their anatomical entry into the skin, while nerves on the right side were left intact. All studies were performed in accordance with regulations established by the University of Michigan Unit for Laboratory Animal Medicine.
Tissue Staining
Biopsies were fixed for 1 hr in cold 3.7% paraformaldehyde, incubated overnight in 30% sucrose at 4 C, before embedding in OCT. Frozen sections were stained using standard protocols with the following antibodies: anti-K17 (D73C7, 1:1,500, Cell Signaling); anti-K8 (TROMA-I, 1:500, Developmental Studies Hybridoma Bank); anti-K20 (D409, 1:500, American Research Products); anti-K14 (AF64, 1:1,000,000, Covance); anti-K5 (03-GP-CK5, American Research Products); anti-GFP/YFP (GFP-1020, 1:2,000, Aves Labs); anti-NF (C28E10, 1:500, Cell Signaling); anti-b4 (346-11A, 1:500, BD PharMingen); anti-Sox9 (H-90, 1:150, Santa Cruz Biotechnology); anti-Lrig1 (AF3688, 1:25, R&D Systems); anti-K10 (PRB-159P, 1:500, Covance); anti-involucrin (PRB-140C, 1:500, Covance); anti-chromogranin A (24-1113C1, 1:250, American Research Products); and anti-CD200 eFluor660 (OX90, 1:2,000, eBioscience). For frozen samples stained for YFP, sections were pre-treated with cold methanol for 5 min prior to blocking. For whole-mount b-gal staining, in situ staining and qPCR, see Supplemental Experimental Procedures. Image processing was performed using Adobe Photoshop CS6, with the Auto-Blend function applied to maximize image sharpness across focal planes in the same microscopic field.
Quantitation
For TDs and TD-derived tumors, 15 non-consecutive frozen sections (each 10 mm thick, 1 cm in length) were analyzed. TDs were identified on the basis of columnar morphology, K17 expression, and association with K8-expressing Merkel cells. TD size was assessed by counting the number of K17+ cells within each cluster along 15 cm of skin. TD-derived tumors were identified on the basis of criteria used for normal TDs, and the total number of K17+ cells within lesions radiating down from the epidermis was scored. K17-expressing cells in the infundibulum were excluded (Veniaminova et al., 2013) . K17 expression is absent in normal non-TD IFE. To quantitate hair follicle-associated tumors in Gli1;Ptch1 mice, we measured tumor volumes from 5 non-consecutive frozen sections (10 mm thick, 1 cm in length) for each sample. We performed immunohistochemistry (IHC) for K17, outlined tumors in Photoshop, and recorded tumor area in pixels. For quantitating ectopic hair buds in K14;Ptch1 mice, we counted the number of cell clusters, defined as consisting of at least three continuous K17+ cells, along the entire IFE.
Human Samples
Human BCCs were obtained with informed consent under institutional review board (IRB) protocol HUM00042233, in accordance with procedures approved by the IRB of the University of Michigan Medical School. Tumor biopsies were processed for paraffin sections and de-identified, and thus not regulated as per IRB guidelines (exempt IRB protocol HUM00051875). 
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